BioSpace

9 Months In, FDA’s New Priority Voucher Program Still Clouded With Uncertainty

The FDA’s Commissioner’s National Priority Voucher program, unveiled in June 2025, is “shrouded in secrecy,” Democratic ...
Fierce Pharma

FDA solicits feedback on controversial national priority voucher review pathway

Since its introduction nine months ago, the FDA’s national priority voucher pilot program has attracted intrigue and fierce ...
Hosted on MSN

Legal questions swirl around FDA's new expedited drug program, including who should sign off

WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the ...
BioSpace

Novo’s High Dose Wegovy Scores FDA Priority Voucher Program’s 4th Nod

With the approval of Wegovy HD, Novo Nordisk joins Johnson & Johnson, Boehringer Ingelheim and USAntibiotics as beneficiaries ...

DifGen Pharmaceuticals and Aveva Drug Delivery Systems Lead U.S. Technology Transfer and Platform Development Collaboration for Multi-Indication Immune Restoration Therapy with ...

DifGen Pharmaceuticals and Aveva Drug Delivery Systems today announced a strategic platform collaboration with Biostax Corp d/b/a Attune Biotech, SGP Holdings, and Callan JMB to lead U.S.-based ...